Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Predictors of Response Outcomes for Research Recruitment Through a Central Cancer Registry: Evidence From 17 Population-Based Studies.

Millar MM, Kinney AY, Camp NJ, Cannon-Albright LA, Hashibe M, Penson DF, Kirchhoff AC, Neklason DW, Gilsenan AW, Dieck GS, Stroup AM, Edwards SL, Bateman C, Carter ME, Sweeney C.

Am J Epidemiol. 2019 Jan 25. doi: 10.1093/aje/kwz011. [Epub ahead of print]

PMID:
30689685
2.

Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer.

Kanth P, Hazel MW, Boucher KM, Yang Z, Wang L, Bronner MP, Boylan KE, Burt RW, Westover M, Neklason DW, Delker DA.

Genes Chromosomes Cancer. 2019 Jan;58(1):23-33. doi: 10.1002/gcc.22686. Epub 2018 Nov 18.

PMID:
30265426
3.

Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.

Sample DC, Samadder NJ, Pappas LM, Boucher KM, Samowitz WS, Berry T, Westover M, Nathan D, Kanth P, Byrne KR, Burt RW, Neklason DW.

BMC Gastroenterol. 2018 Jul 16;18(1):115. doi: 10.1186/s12876-018-0841-8.

4.

Pancreatic cancer as a sentinel for hereditary cancer predisposition.

Young EL, Thompson BA, Neklason DW, Firpo MA, Werner T, Bell R, Berger J, Fraser A, Gammon A, Koptiuch C, Kohlmann WK, Neumayer L, Goldgar DE, Mulvihill SJ, Cannon-Albright LA, Tavtigian SV.

BMC Cancer. 2018 Jun 27;18(1):697. doi: 10.1186/s12885-018-4573-5.

5.

Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.

Samadder NJ, Kuwada SK, Boucher KM, Byrne K, Kanth P, Samowitz W, Jones D, Tavtigian SV, Westover M, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Burt RW, Neklason DW.

JAMA Oncol. 2018 May 1;4(5):671-677. doi: 10.1001/jamaoncol.2017.5431.

6.

POLR2C Mutations Are Associated With Primary Ovarian Insufficiency in Women.

Moriwaki M, Moore B, Mosbruger T, Neklason DW, Yandell M, Jorde LB, Welt CK.

J Endocr Soc. 2017 Feb 7;1(3):162-173. doi: 10.1210/js.2016-1014. eCollection 2017 Mar 1.

7.

Primary Ovarian Insufficiency and Azoospermia in Carriers of a Homozygous PSMC3IP Stop Gain Mutation.

Al-Agha AE, Ahmed IA, Nuebel E, Moriwaki M, Moore B, Peacock KA, Mosbruger T, Neklason DW, Jorde LB, Yandell M, Welt CK.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):555-563. doi: 10.1210/jc.2017-01966.

8.

Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia.

Delker DA, Wood AC, Snow AK, Samadder NJ, Samowitz WS, Affolter KE, Boucher KM, Pappas LM, Stijleman IJ, Kanth P, Byrne KR, Burt RW, Bernard PS, Neklason DW.

Cancer Prev Res (Phila). 2018 Jan;11(1):4-15. doi: 10.1158/1940-6207.CAPR-17-0130. Epub 2017 Nov 6.

9.

Outcomes and complications of radiation therapy in patients with familial adenomatous polyposis.

Gan M, Boothe D, Neklason DW, Samadder NJ, Frandsen J, Keener MB, Lloyd S.

J Gastrointest Oncol. 2017 Aug;8(4):643-649. doi: 10.21037/jgo.2017.03.01.

10.

Population-based description of familial clustering of Chiari malformation Type I.

Abbott D, Brockmeyer D, Neklason DW, Teerlink C, Cannon-Albright LA.

J Neurosurg. 2018 Feb;128(2):460-465. doi: 10.3171/2016.9.JNS161274. Epub 2017 Feb 3.

PMID:
28156254
11.

A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.

Bong YS, Assefnia S, Tuohy T, Neklason DW, Burt RW, Ahn J, Bueno De Mesquita PJ, Byers SW.

Oncotarget. 2016 Dec 6;7(49):80508-80520. doi: 10.18632/oncotarget.12768.

12.

Sulindac and Erlotinib for Familial Adenomatous Polyposis--Reply.

Samadder NJ, Neklason DW, Burt RW.

JAMA. 2016 Aug 2;316(5):545. doi: 10.1001/jama.2016.7595. No abstract available.

PMID:
27483082
13.

Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.

Li J, Woods SL, Healey S, Beesley J, Chen X, Lee JS, Sivakumaran H, Wayte N, Nones K, Waterfall JJ, Pearson J, Patch AM, Senz J, Ferreira MA, Kaurah P, Mackenzie R, Heravi-Moussavi A, Hansford S, Lannagan TRM, Spurdle AB, Simpson PT, da Silva L, Lakhani SR, Clouston AD, Bettington M, Grimpen F, Busuttil RA, Di Costanzo N, Boussioutas A, Jeanjean M, Chong G, Fabre A, Olschwang S, Faulkner GJ, Bellos E, Coin L, Rioux K, Bathe OF, Wen X, Martin HC, Neklason DW, Davis SR, Walker RL, Calzone KA, Avital I, Heller T, Koh C, Pineda M, Rudloff U, Quezado M, Pichurin PN, Hulick PJ, Weissman SM, Newlin A, Rubinstein WS, Sampson JE, Hamman K, Goldgar D, Poplawski N, Phillips K, Schofield L, Armstrong J, Kiraly-Borri C, Suthers GK, Huntsman DG, Foulkes WD, Carneiro F, Lindor NM, Edwards SL, French JD, Waddell N, Meltzer PS, Worthley DL, Schrader KA, Chenevix-Trench G.

Am J Hum Genet. 2016 May 5;98(5):830-842. doi: 10.1016/j.ajhg.2016.03.001. Epub 2016 Apr 14.

14.

Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype.

Kanth P, Bronner MP, Boucher KM, Burt RW, Neklason DW, Hagedorn CH, Delker DA.

Cancer Prev Res (Phila). 2016 Jun;9(6):456-65. doi: 10.1158/1940-6207.CAPR-15-0363. Epub 2016 Mar 29.

15.

Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.

Samadder NJ, Neklason DW, Boucher KM, Byrne KR, Kanth P, Samowitz W, Jones D, Tavtigian SV, Done MW, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Davis R, Topham MK, Lynch P, Strait E, McKinnon W, Burt RW, Kuwada SK.

JAMA. 2016 Mar 22-29;315(12):1266-75. doi: 10.1001/jama.2016.2522.

16.

Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.

Neklason DW, VanDerslice J, Curtin K, Cannon-Albright LA.

Endocr Relat Cancer. 2016 Feb;23(2):93-100. doi: 10.1530/ERC-15-0442. Epub 2015 Nov 24.

17.

Confidentiality & the Risk of Genetic Discrimination: What Surgeons Need to Know.

Gammon A, Neklason DW.

Surg Oncol Clin N Am. 2015 Oct;24(4):667-81. doi: 10.1016/j.soc.2015.06.004. Epub 2015 Jul 16. Review.

18.

APC promoter 1B deletion in seven American families with familial adenomatous polyposis.

Snow AK, Tuohy TM, Sargent NR, Smith LJ, Burt RW, Neklason DW.

Clin Genet. 2015 Oct;88(4):360-5. doi: 10.1111/cge.12503. Epub 2014 Oct 14.

19.

RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers.

Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, Burt RW, Hagedorn CH.

PLoS One. 2014 Feb 12;9(2):e88367. doi: 10.1371/journal.pone.0088367. eCollection 2014.

20.

Shared genomic segment analysis: the power to find rare disease variants.

Knight S, Abo RP, Abel HJ, Neklason DW, Tuohy TM, Burt RW, Thomas A, Camp NJ.

Ann Hum Genet. 2012 Nov;76(6):500-9. doi: 10.1111/j.1469-1809.2012.00728.x. Epub 2012 Sep 19.

21.

Activating mutation in MET oncogene in familial colorectal cancer.

Neklason DW, Done MW, Sargent NR, Schwartz AG, Anton-Culver H, Griffin CA, Ahnen DJ, Schildkraut JM, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Burt RW.

BMC Cancer. 2011 Oct 4;11:424. doi: 10.1186/1471-2407-11-424.

22.

Maximum-likelihood estimation of recent shared ancestry (ERSA).

Huff CD, Witherspoon DJ, Simonson TS, Xing J, Watkins WS, Zhang Y, Tuohy TM, Neklason DW, Burt RW, Guthery SL, Woodward SR, Jorde LB.

Genome Res. 2011 May;21(5):768-74. doi: 10.1101/gr.115972.110. Epub 2011 Feb 8.

23.

Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer.

Neklason DW, Tuohy TM, Stevens J, Otterud B, Baird L, Kerber RA, Samowitz WS, Kuwada SK, Leppert MF, Burt RW.

J Med Genet. 2010 Oct;47(10):692-9. doi: 10.1136/jmg.2009.076091. Epub 2010 Jun 3.

24.

Hereditary and familial colon cancer.

Jasperson KW, Tuohy TM, Neklason DW, Burt RW.

Gastroenterology. 2010 Jun;138(6):2044-58. doi: 10.1053/j.gastro.2010.01.054. Review.

25.

Large intron 14 rearrangement in APC results in splice defect and attenuated FAP.

Tuohy TM, Done MW, Lewandowski MS, Shires PM, Saraiya DS, Huang SC, Neklason DW, Burt RW.

Hum Genet. 2010 Mar;127(3):359-69. doi: 10.1007/s00439-009-0776-9. Epub 2009 Dec 22.

26.

Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis.

Jasperson KW, Vu TM, Schwab AL, Neklason DW, Rodriguez-Bigas MA, Burt RW, Weitzel JN.

Fam Cancer. 2010 Jun;9(2):99-107. doi: 10.1007/s10689-009-9290-4. Erratum in: Fam Cancer. 2013 Sep;12(3):583.

27.

Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.

Neklason DW, Kerber RA, Nilson DB, Anton-Culver H, Schwartz AG, Griffin CA, Lowery JT, Schildkraut JM, Evans JP, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Finkelstein DM, Nadkarni PM, Kasten CH, Mineau GP, Burt RW.

Cancer Res. 2008 Nov 1;68(21):8993-7. doi: 10.1158/0008-5472.CAN-08-1376.

28.

Colonic adenoma risk in familial colorectal cancer--a study of six extended kindreds.

Neklason DW, Thorpe BL, Ferrandez A, Tumbapura A, Boucher K, Garibotti G, Kerber RA, Solomon CH, Samowitz WS, Fang JC, Mineau GP, Leppert MF, Burt RW, Kuwada SK.

Am J Gastroenterol. 2008 Oct;103(10):2577-84. doi: 10.1111/j.1572-0241.2008.02019.x. Epub 2008 Jul 30.

29.

American founder mutation for attenuated familial adenomatous polyposis.

Neklason DW, Stevens J, Boucher KM, Kerber RA, Matsunami N, Barlow J, Mineau G, Leppert MF, Burt RW.

Clin Gastroenterol Hepatol. 2008 Jan;6(1):46-52. Epub 2007 Dec 11.

30.

Gonadal mosaicism and familial adenomatous polyposis.

Schwab AL, Tuohy TM, Condie M, Neklason DW, Burt RW.

Fam Cancer. 2008;7(2):173-7. Epub 2007 Nov 18.

PMID:
18026870
31.

Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt/beta-catenin independent mechanism.

Tsai IC, Woolf M, Neklason DW, Branford WW, Yost HJ, Burt RW, Virshup DM.

Int J Cancer. 2007 Mar 1;120(5):1005-12.

32.
33.

Genetic testing for inherited colon cancer.

Burt R, Neklason DW.

Gastroenterology. 2005 May;128(6):1696-716. Review.

PMID:
15887160
34.

Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis.

Burt RW, Leppert MF, Slattery ML, Samowitz WS, Spirio LN, Kerber RA, Kuwada SK, Neklason DW, Disario JA, Lyon E, Hughes JP, Chey WY, White RL.

Gastroenterology. 2004 Aug;127(2):444-51.

PMID:
15300576
35.

Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype.

Neklason DW, Solomon CH, Dalton AL, Kuwada SK, Burt RW.

Fam Cancer. 2004;3(1):35-40.

PMID:
15131404
36.

Biochemical variants of Smith-Lemli-Opitz syndrome.

Neklason DW, Andrews KM, Kelley RI, Metherall JE.

Am J Med Genet. 1999 Aug 27;85(5):517-23.

PMID:
10405455
37.

Role of multidrug resistance P-glycoproteins in cholesterol esterification.

Debry P, Nash EA, Neklason DW, Metherall JE.

J Biol Chem. 1997 Jan 10;272(2):1026-31.

38.

Determining the requirements for cooperative DNA binding by Swi5p and Pho2p (Grf10p/Bas2p) at the HO promoter.

Brazas RM, Bhoite LT, Murphy MD, Yu Y, Chen Y, Neklason DW, Stillman DJ.

J Biol Chem. 1995 Dec 8;270(49):29151-61.

Supplemental Content

Loading ...
Support Center